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Risk-Attributable Burden of Chronic Diseases and
Cost of Prevention in Bangladesh
Andrew Mirelman , Tracey Pe´rez Koehlmoos , Louis W. Niessen ,
Baltimore, MD, USA; and Dhaka, BangladeshTo address the increasing burden from noncom-
municable diseases (NCD) in Bangladesh, new epi-
demiologic and economic information for risk
factors are needed. This work quantified the attrib-
utable risk from specific NCD risk factors and
undertook a costing exercise for prevention of
NCD risk factors. We used available data for Ban-
gladesh and implemented an iterative questionnaire
process with local experts to calculate risk factor
population attributable fractions and establish
resource requirements for NCD prevention. The
burden analysis showed that myocardial infarction
and stroke occurrence can be greatly reduced by risk
factor control. From the costing, we found that
$3.95 USD per capita is needed for a prevention
program, which is 26% of the total expenditure
on health. These estimates should facilitate advo-
cacy for setting expenditure targets and identifying
financing mechanisms to address NCD. The infor-
mation supports the scaling-up of NCD prevention
strategies in Bangladesh and serves as a model for
work in developing country settings.NONCOMMUN I CAB L E D I S E A S E S AND
R I S K FAC TOR S I N BANG LAD E SH
Addressing the noncommunicable disease (NCD)
burden is proving to be an important and increas-
ingly acknowledged issue on the global health agen-
da. The momentum for global efforts to address
prevention and control of the burden from NCD
has been high in recent years leading to a culmina-
tion at the United Nations’ High-Level Meeting ofThis research was supported by the Institute of Medicine; National Institutes–
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ments confirmed the need for an action agenda.
In low-resource countries, the fight against rising
levels of NCD has only begun. In most of these set-
tings, global health support efforts have been fo-
cused on communicable diseases, and building
capacity for intervention strategies and surveillance
for NCD is novel.
This special issue of Global Heart highlights
important efforts that are taking place worldwide
to support the planning and implementation pro-
cess in countries for NCD control efforts. The ini-
tial results presented in this work demonstrate a
process for collecting and using the best available
country-specific data sources and input from coun-
try-level experts to estimate epidemiological burden
and the costs for intervention strategies. This work
focuses on Bangladesh, where the advancing epide-
miologic transition from communicable diseases to
NCD is underway and is projected to accelerate
over the next two decades [1].
Resources for NCD are limited in any setting,
and the most economically viable solutions for
disease control are through primary prevention,
i.e., reductions of NCD risk factor levels leading
to reduced disease incidence. Here, we define a risk
factor as an underlying cause of the disease that
often is part of a complex pathway of multiple
individual risk factors leading to the onset of disease
[2]. Many risk factors for NCD are modifiable, and
reduction of major risk factors could lead to a
reduction in disease incidence of up to 50% [3].
An agenda addressing NCD risk factors requires
information about the risk factors’ epidemiologyNational Heart, Lung, and Blood Institute; and the United Health Group.
ntents of this paper to disclose.
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NCD risk factor definitions
 Hypertension: systolic blood pressure >140 mm
Hg or diastolic blood pressure <90 mm Hg.
 Elevated cholesterol: >200 mg/dl.
 Smoking: daily and nondaily user of cigarettes.
 BMI: overweight (25.0–29.9) or obese (>30.0).
 Inactivity: prevalence of nonengagement in
moderate physical activity.
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estimates of primary prevention efforts are impor-
tant and provide a key step to mobilize local and
international political and financial support. There
are strong economic arguments to address the
NCD burden in developing countries where a siz-
able burden occurs in younger, working-age popu-
lations, which reduces labor productivity and leads
to negative economic impacts for households [4,5].
For Bangladesh, research on the economics of
NCD has been largely lacking [6].
Several efforts to estimate the burden of risk fac-
tors in the Bangladeshi population have been
undertaken. In 2002, a stepwise approach to sur-
veillance survey (STEPS) conducted by the World
Health Organization (WHO) suggested that pre-
ventable risk factors, including tobacco, unhealthy
diets, physical inactivity, and alcohol, are becoming
an increasing problem in the country [7]. A sepa-
rate survey using the STEPS methodology in the
subdistrict of Matlab in 2005 cast further light on
the characteristics of households and individuals
that were likely to have NCD risk factors. The re-
sults showed that there were high levels of many
risk factors and that their distribution across char-
acteristics such as age, sex, and socioeconomic sta-
tus were varying [8]. Countrywide, evidence
suggests that there are high rates of any tobacco
use, particularly among men (men: rural: 52%, ur-
ban: 41%; women: rural: 29%, urban: 17%); moder-
ate rates of fruit and vegetable consumption among
adults (vegetables: 3.2 servings daily; fruit: 1.7 serv-
ings daily); and high rates of physical inactivity
among adults, particularly women (men: 35%; wo-
men: 64%) [9–11].
The consequences of neglecting to address
NCD risk factors now are high. If current trends
of NCD-related risk factors in Bangladesh are
maintained, then many deaths will occur in the fu-
ture that could have been prevented. A recent
household survey in Bangladesh estimated that to-
bacco-related illnesses were responsible for 16% of
all deaths in the country [9,12]. Further case–con-
trol studies have shown that strong linkages be-
tween tobacco smoking and cardiovascular disease
(CVD) exist in Bangladesh and that smokeless to-
bacco can have devastating effects [13].
Currently in Bangladesh, several efforts adapt
existing health services to address the NCD burden
[12]. As a comprehensive approach to addressing
risk factors, though, these efforts focus on informa-
tion gathering and ad hoc intervention programs
with passive case finding. For the country to takesteps to address NCD risk factors, information
from many sources needs to be collated, synthe-
sized, and made available to decision makers. This
paper provides some initial results from ongoing
work that focuses on accessing multiple sources of
information within Bangladesh to estimate the epi-
demiologic burden and the costs of NCD risk fac-
tor intervention strategies.E S T IMAT I NG THE R I S K FA C TOR –
A T T R I BU TAB L E BURD EN
To estimate the risk factor burden, we used the epi-
demiologic concept of population-attributable frac-
tion (PAF) to prioritize specific risk factors in
prevention and control programs. The PAF is de-
fined as the amount of disease incidence that is
attributed to a specific risk factor or the amount
of potential decrease in disease incidence that can
be expected if that risk factor were completely elim-
inated [14,15]. A secondary parameter to the PAF
is the multiple population-attributable ratio
(MPAR), which combines the PAF multiplica-
tively to give the total amount of disease incidence
that would be averted if all the risk factors were
eliminated [15,16]. Clustering of risk factors or
joint occurrence in single individuals is shown to
be potentially important in older and less-educated
populations in Bangladesh but has not yet taken
into account in this analysis [17].
Risk factors for this exercise were chosen based
on strength of evidence and importance for
addressing the NCD burden in Bangladesh. The
five selected risk factors were a combination of
behavioral and biologic risk factors using standard
definitions set out by WHO [18]. The risk factors
chosen were hypertension, elevated cholesterol,
smoking, body mass index (BMI), and inactivity
(see Box). On the disease side, five NCD that
are prevalent in Bangladesh and associated with
the risk factors were selected for the analysis. These
included two forms of CVD, including myocardial
Figure 1. Combined multiple population-attributable ratio
(MPAR) for the selected risk factors and diseases. COPD,
chronic obstructive pulmonary disorder; DM, diabetes mellitus; MI,
myocardial infarction.
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pulmonary disorder (COPD); lung cancer; and
diabetes mellitus (DM).
The data for all risk factors except elevated cho-
lesterol are preliminary data from the latest WHO
STEPS report for Bangladesh (to be released in
2012), which recorded prevalence data on risk fac-
tors in the adult population over 25 years old. Be-
cause cholesterol information was not available
from the STEPS report, elevated cholesterol prev-
alence was reported from a rural survey from 1996
[19]. Relative risk information for each risk factor
and its associated diseases are difficult to obtain
for a low-income setting such as Bangladesh, or
even the South East Asia region. We assumed that
relative risks are maintained across different coun-
tries and regions and used previous estimates from
sources using relative risks for the same risk factors,
which has been previously justified [20,21].
The results for the MPAR calculations broken
down by sex are shown in Figure 1. For both sexes,Figure 2. Population-attributable fraction (PAF) distribution resultthe largest reduction in disease comes from
addressing the risk factors associated with stroke.
For men, there is also a high level of COPD and
lung cancer that is preventable, and significant pro-
portions of DM and MI are also preventable. In
women, the amount of preventable MI is higher
than that for men, and the levels of COPD and
lung cancer are quite a bit lower. Figure 2 shows
the percentage of each portion of the preventable
level of disease that is attributed to each risk factor.
Because smoking is the sole factor associated with
COPD and lung cancer, we see that the higher
prevalence of smoking in men is what leads to
the higher preventable levels. For MI, hypertension
plays a major role for both sexes, followed by
smoking for men and inactivity for women. Stroke
shows similar trends, with an even greater contri-
bution from inactivity and, especially for women,
elevated BMI. The major risk factor contributions
for DM result from hypertension, elevated BMI,
and inactivity for both sexes. Overall, hypertension,
smoking, and inactivity contributed the most as
risk factors. Elevated cholesterol, alcohol consump-
tion, and higher BMI showed less impact on the
selected diseases.
These results show that, especially for men,
known risk factors contribute to large proportions
of disease occurrence. This is also true for women
in the case of MI and stroke. The amount of avail-
able evidence on NCD is limited for Bangladesh.
Our calculations show that some risk factors are
more important than others are and that MI and
stroke occurrence in both sexes, as well as smok-
ing-related diseases in men, can be greatly reduced
by risk factor control.COS T I NG O F R I S K F AC TOR PR EV ENT I ON
S T RA T EG I E S
In addition to the burden estimation, we also con-
ducted a costing exercise for risk factor preventions by sex. Abbreviations as in Figure 1.
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framework for costing, based on the approaches
by WHO, and used a country-specific validation
process to obtain cost estimates [22,23]. We di-
vided costs into two broad categories: patient costs,
which include the unit prices of resources; and pro-
gram costs, which include administrative, educa-
tion, and training costs, among others. The
costing took into account estimates for preventive
interventions that specifically addressed elevated
blood pressure and cholesterol. These include diag-
nostic testing and first- and second-line medica-
tions such as statins, diuretics, and beta-blockers
for lowering cholesterol and blood pressure. Cost-
ing components addressed additional risk factors
indirectly through programmatic costs established
at the national, divisional, district, and community
levels.
A self-administered questionnaire was devel-
oped for costing estimates, based on an earlier
NCD-costing exercise done in China and a global
maternal and child health–costing exercise [20,23].
To capture all of the appropriate cost drivers, the
survey consisted of three types of questions: risk
factor epidemiology; economic costs of the individ-
ual-based interventions; and questions on the func-
tioning and size of CVD prevention programs. The
questionnaires were pre-populated with the most
recent global, publicly available information from
databases such as WHO Global Infobase [24],
WHO CHOICE costing database [25], and Man-
agement Sciences for Health drug price indicator
database [26]. Minimum and maximum estimates
were also requested for relevant parameters for
inclusion in sensitivity analyses.
Once the available information was compiled in
the questionnaire, it was circulated to country ex-
perts for a validation procedure. In this process, lo-
cal qualified health economists and administrators
(n = 5) were identified and contacted to either con-
firm that the information in the questionnaire was
correct or to provide more accurate information.Table 1. Price tag for prevention in Bangladesh and SEAR
2010 Population Per capita total
expenditure on
health 2007 (US$)a
Per capita
governme
expenditu
health 200
Bangladesh 164,424,000 15.00 5.00
SEAR 1611,408,000 41.00 15.00
Adapted, with permission, from WHO [28].
SEAR, South East Asia region.
a Average exchange rate.The respondents provided new estimates of the
costs from sources such as the existing Ministry
of Health salary and benefit rates for health work-
ers at various levels, previous or ongoing costing
projects, and the market prices for drugs as re-
ported by expert pharmacists. Validated epidemiol-
ogy data for risk factor prevalence were based on a
national population sample using the STEPS pro-
tocol, updating the WHO 2002 estimates for the
year 2011. Standard case-management protocols
were provided in the questionnaires for validation
by the country experts as well. These provided an-
other source of variation across countries and have
implications for costs.
A costing model was developed in Microsoft
Excel (Redmond, Washington) with Palisade’s
@Risk add-on (Ithaca, New York) for probabilistic
analysis. The model used all of the validated coun-
try cost and epidemiologic information to generate
the total cost of prevention and associated confi-
dence intervals. The 2010 Bangladesh population
estimate from the UN Population Division [27]
was used to calculate a country total cost per capita
for CVD risk factor prevention strategies. The pre-
liminary results for both Bangladesh and the entire
South East Asia region are available in Table 1.
Overall, the validated costing estimates were higher
than the pre-populated estimates for the South
East Asia region. In Bangladesh, the validated esti-
mate rose 28% during the country validation proce-
dure to the final estimate of US$3.95 per capita
(denoted: ‘‘Validated Total Cost per Capita of Pre-
vention Strategies’’). This estimate is around 26%
of the total expenditure on health in the country
and 79% of the government expenditure on health
[28]. Relative to the average cost of prevention for
the South East Asia region, the cost for prevention
in Bangladesh represents a relatively affordable
proposition. To account for levels of uncertainty
in the evidence and outcomes, sensitivity analyses
were also conducted using probabilistic techniques,
though they are not presented here.nt
re on
7 (US$)a
Validated total
cost per capita
of prevention
strategies
% of total
expenditure
% of government
expenditure
3.95 26 79
27.19 66 181
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perspective, meeting the needs of risk factor pre-
vention requires an increase in resources from gov-
ernment, private sector, and external aid
organizations. Further study on averted cost of ill-
ness and economic impact should also be con-
ducted for conclusions about the cost-
effectiveness of these programs. Another outcome
of this work is the emphasis on the country-level
validation process. The work involved bringing to-
gether relevant NCD stakeholders in the country
and compiling risk factor epidemiologic and eco-
nomic data that has been collected in different
places and times. The use of such a validation pro-
cess helped ensure that there was appropriate buy-
in and input from experts in the country who are
concurrently working on NCD.D I S CU S S I ON
Bangladesh, as a developing country, is moving for-
ward with including noncommunicable diseases on
its health agenda. Even though the country’s large
inequalities and rampant poverty represent a general
case of issues facing developing settings, especially
those in Southeast Asia, many of the solutions will
have to account for the starkly different profiles of
risk factors even within similar countries [17].
A limitation of our work is the lack of quality
data. Data limitations made it difficult to model
risks related to unhealthy diet and the lack of con-
sumption of fruits and vegetables. Improved data is
needed for program monitoring and predicting fu-
ture burden. Further work to identify the major
gaps in risk factor data in Bangladesh should follow
in the steps of recent work in India, which takes
into account country-specific risks [29].
Data on the epidemiology of diseases and risk
factors could serve as important tools for establish-
ing priorities for NCD prevention and manage-
ment in the future. Specifically, more should be
done to obtain basic indicators of disease preva-
lence and mortality. For risk factors, there is an ur-
gent need to establish the prevalence of elevated
cholesterol. More data is also needed on relative
risks and degrees of risk factor clustering among
the population. With this in mind, even in devel-
oped countries, some disease and risk factor infor-
mation is difficult to obtain such as prevalence
levels of pre-diabetes and causal linkages between
salt intake and CVD.
For determining a cost of prevention, our work
only uses information from the public sector and islimited by the lack of data from the private sector.
Because the costs and coverage of the private sector
is unknown, our cost estimates only represent a min-
imum of what is needed. Adding information for the
private sector would provide a fuller picture of the
costing landscape and, predictably, would increase
the total prevention cost by a considerable amount.
Costing studies will also be vital to provide deci-
sion makers with estimates of the amount of re-
sources required. Several costing components will
continue to be difficult to measure in a lower-in-
come country such as Bangladesh. These include
the intensity and cost of providing community
health workers at the neighborhood levels and
the extent of facility- versus community-level care
for selected interventions and the quality of care
provided. Regardless, assumptions will need to be
made to obtain an appropriate cost for program
introduction and scale-up, and sensitivity analysis
methodologies provide a solution to determining
the levels of certainty around these estimates.
New cost estimates have the potential to facilitate
advocacy, set targets for appropriate expenditure
on health, and help identify funding and financing
mechanisms for neglected health issues [23]. With
reliable cost estimates, a co-coordinating and nego-
tiating national mechanism could provide strong
leverage for a prevention program that includes
both the private and public sector, is involved in
price setting, and that contributes to adequate ef-
forts for monitoring and evaluation.
The work that has been done for NCD in Ban-
gladesh is beginning to shed new light on the scale
of the problem. The country has inequalities in dis-
ease and risk factor distribution and health-seeking
behavior between urban and rural populations and
between groups of rich and poor [30]. Tackling
this issue is vital to continue the fight against pov-
erty in the country. We have shown that working
at the country level through iterative processes with
experts provides leverage for unifying the relevant
actors and generating local capacity to produce
country-specific information on disease burden
and costs, information that demonstrates resource
needs that can be used to support scaling up of
NCD prevention strategies for the Bangladeshi
people.ACKNOWLEDGMENT
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